Zerbaxa does not contain a bacteriostatic preservative. Ceftolozanetazobactam zerbaxa national drug monograph. In a clinical trial, patients with ciais with crcl 50 mlmin had a clinical cure rate of 85. Dailymed zerbaxa ceftolozane and tazobactam injection. This site is intended for us health care professionals only. Left ventricular dysfunction and embryofetal toxicity see full prescribing information for complete boxed warning. Zerbaxa fda prescribing information, side effects and uses. It is a wellknown fact that we are in a crisis, and we are running out of time. The in vitro spectrum of cts activity includes both susceptible and multidrugresistant mdr strains of pseudomonas aeruginosa. Merck was found to be noninferior to meropenem in the treatment of adult patients with either ventilated.
It is indicated for the treatment of adult patients with complicated urinary tract infections cuti including acute pyelonephritis, and in combination with metronidazole, complicated intraabdominal infections ciai. Aseptically transfer the required dose of reconstituted dalbavancin solution. Side effects of zerbaxa ceftolozane and tazobactam for. Leftover mic test strip from an opened package must be stored at 28c in the airtight tube, containing desiccant, provided in the pack for no more than 7 days. Upon constitution with sterile water for injection or 0. Zosyn is a monosodium salt of piperacillin and a monosodium salt of tazobactam containing a. Cephalosporin that has demonstrated potent in vitro activity against pseudomonas aeruginosa. Ceftaroline is a cephalosporin within vitroactivity against grampositive and negative bacteria. The reality is people are dying of multidrugresistant pathogens, particularly gramnegative bacilli. Etest strips must be kept dry with active desiccant. It retains the activity of latergeneration cephalosporins having broadspectrum activity against gramnegative bacteria.
Do not use the etest gradient strips if the package has been damaged. Highlights of prescribing information zerbaxa 750 mg 250 mg. The unopened package of ceftolozanetazobactam mic test strip should be stored at. Infusion to reduce the development of drugresistant bacteria and maintain the effectiveness of.
Follow all directions on your medicine label and package. Zerbaxa ceftolozanetazobactam is an antibacterial drug product composed of a cephalosporin and a beta lactamase inhibitor. Selected safety information patients with renal impairment. What drugs, substances, or supplements interact with zerbaxa. Ceftolozanetazobactam pharmacokinetics in a critically. The crisis of bad bugs, no drugs has led to the infectious diseases society of america 10 x 20 initiative, the national action plan for combating antibioticresistant bacteria, carbx, and other efforts to combat or call attention to drugresistant bacteria. The recommended dose of zerbaxa in adult patients with habpvabp and creatinine clearance crcl greater than 50 mlmin is 3 grams two 1. Zerbaxa ceftolozane and tazobactam for injection, for intravenous use drug information pdf dosing. Handling before using the etest gradient strips from an unopened package, visually inspect to ensure the package is intact. Highlights of prescribing information these highlights do not include all the information needed to use emgality safely and effectively. Ceftolozane belongs to the cephalosporin class of antibacterial drugs.
Zerbaxa was evaluated in phase 3 comparatorcontrolled clinical trials of ciai and cuti, which included a total of 1015 patients treated with zerbaxa 1. Merck was found to be noninferior to meropenem in the treatment of adult patients with either ventilated hospitalacquired bacterial pneumonia habp or. Patients are calculated based on an estimated annual cumulative dose. The prescribing information for ceftolozanetazobactam warns of possible allergic. Ceftolozane has been proven to have greater affinity for pbps when compared with ceftazidime and imipenem. Of note, vaborbactam does not improve the effect of meropenem versus acinetobacter spp. Perjeta can result in subclinical and clinical cardiac failure manifesting as decreased lvef and chf. Highlights of prescribing information zinplavasafely and. Zinplava is not indicated for the treatment of cdi. The package insert states decreased efficacy seen in patients with a baseline creatinine clearance 50 mlmin had a clinical cure rate of 85. Highlights of prescribing information neulasta safely and. This product information was approved at the time this auspar was published. Complicated intraabdominal infections zerbaxa used in combination with metronidazole is indicated for the treatment of complicated intraabdominal infections. The recommended dosage regimen of zerbaxa for injection is 1.
To the editor ceftolozanetazobactam ct has recently been approved in the united states for the treatment of complicated urinary tract infections and, in conjunction with metronidazole, for intraabdominal infections. The package insert states decreased efficacy seen in patients with a baseline creatinine clearance escherichia coli, haemophilus influenzae, klebsiella oxytoca, klebsiella pneumoniae, proteus mirabilis, pseudomonas aeruginosa. Successful treatment of multidrugresistant pseudomonas. Zerbaxa was evaluated in phase3 comparatorcontrolled clinical trials of complicated intraabdominal infections and complicated urinary tract infections including pyelonephritis, which included a total of 1,015patients, treated with zerbaxa 1g0. Full prescribing information 1 indications and usage zinplavais indicated to reduce recurrence of clostridium difficile infectioncdi in patients 18 years of age or older who are receiving antibacterial drug treatment of cdi and are at a high risk for cdi recurrence. Neulasta pegfilgrastiminjection,for subcutaneous use initial u. Indicated for complicated urinary tract infections cuti, including pyelonephritis, caused by escherichia coli, klebsiella pneumoniae, proteus mirabilis, and pseudomonas aeruginosa. Oct 16, 2017 like avibactam and tazobactam, vaborbactam protects its betalactam from degradation by enzymes produced by multidrugresistant gram negative bacteria.
Ceftolozanetazobactam mic test strip technical sheet. Zerbaxa ceftolozane tazobactam for injection, for intravenous use. Ambisome amphotericin b liposome for injection description ambisome for injection is a sterile, nonpyrogenic lyophilized product for intravenous infusion. Reconstituted vials may be stored either refrigerated at 2 to 8 c 36 to 46 f, or at controlled room temperature 20 to 25 c 68 to 77 f. Engerixb can be given on either dosing schedule 0, 1, and 6 months or 0, 1, 2, and 12 months.
Register to receive product and educational information from tetraphase, its affiliates, and service providers. Repeated antibiotic courses, without correcting the fistula, resulted in infection with mdr pseudomonas aeruginosa. Ceftolozanetazobactam mic test strip technical sheet introduction lio. Zerbaxa may also be used for purposes not listed in this medication guide. Zerbaxa solution may be held for 1 hour prior to transfer and dilution in a suitable infusion bag. Engerixb is indicated for immunization against infection. Dec 31, 2019 zerbaxa was evaluated in phase 3 comparatorcontrolled clinical trials of ciai and cuti, which included a total of 1015 patients treated with zerbaxa 1. Highlights of prescribing information zerbaxa 750 mg 250. Ceftolozanetazobactam therapy of respiratory infections. Zerbaxa, a combination of ceftolozane and tazobactam, is used for enterobacteriaceae and pseudomonas aeruginosa infections. Highlights of prescribing information see full prescribing.
Zerbaxa s approval was the 4th antibiotic approved by the fda in 2014, after a long dry spell during which many pharmaceutical companies had largely abandoned the antibiotics market. We present a case of a man aged 64 years with a bladder fistula due to radiation, ultimately causing osteomyelitis of the pubic symphysis. Vaborbactam also does not work against metallobetalactamases. Zerbaxa ceftolozane and tazobactam is a combination of ceftolozane, a cephalosporin antibacterial, and tazobactam, a betalactamase inhibitor, indicated in patients 18 years or older for the treatment of the following infections caused by designated susceptible microorganisms. It was originally isolated from chromobacterium violaceum. Zerbaxa ceftolozanetazobactam dose, indications, adverse. Zerbaxa 750 mg 500 mg and 250 mg followed by a zerbaxa 150 mg 100 mg and 50 mg maintenance dose administered intravenously every 8 hours for the remainder of the treatment period on hemodialysis days, administer the dose at the earliest possible time following completion of dialysis a single loading dose of zerbaxa 2. Minibag plus systems, viaflex containers and vialmate adaptor devices are rx only. The recommended dosage of zerbaxa for injection is 1. New antibiotic options are needed for the treatment of multidrugresistant mdr pseudomonas infections. Etest is supplied in a package of 30 or 100 test strips depending on package format of one antimicrobial agent.
Compatible with standard 20 mm closure, singledose, powdereddrug vials. Decreased efficacy of zerbaxa has been observed in patients with baseline crcl of 30 to. Complicated urinary tract infections cuti, including pyelonephritis 1. Hu y, turner mj, shields j, gale ms, hutto e, roberts bl, et al. Investigation of the mechanism of action of alemtuzumab in a human cd52 transgenic mouse model. The infectious diseases society of america idsa voiced its happiness at zerbaxa s approval in a press release, saying. Ceftolozanetazobactam zerbaxa, merck september 2015.
Please also see full prescribing information for azactam. Zerbaxa ceftolozanetazobactam for injection package insert. The bactericidal action of ceftolozane results from inhibition of cell wall. Etest is a quantitative technique for determining the antimicrobial susceptibility of gramnegative and grampositive aerobic bacteria such. Ceftolozanetazobactam is a novel oxyiminoaminothiazolyl cephalosporin and. Emgality galcanezumabgnlm injection, for subcutaneous use initial u. Enterobacter cloacae, escherichia coli, haemophilus influenzae, klebsiella oxytoca, klebsiella pneumoniae, proteus mirabilis, pseudomonas aeruginosa, and. For the safe and proper use of the devices referenced within, refer to the complete instructions for use or the appropriate manual. Indicated for treatment of hospitalacquired bacterial pneumonia and ventilatorassociated bacterial pneumonia habp. Pseudomonas aeruginosa is a common cause of healthcareassociated pneumonia and ventilatorassociated pneumonia. The diluted solution must have a final dalbavancin concentration of 1 mgml to 5 mgml. Zerbaxa is sometimes given in combination with another antibiotic medicine. Ceftolozanetazobactam zerbaxa is the combination of cephalosporin ceftolozane plus betalactamase inhibitor tazobactam. Venofer is indicated for the treatment of iron deficiency anemia in patients.
Zerbaxa is being prescribed for the treatment of complicated urinary tract infections cuti, including pyelonephritis, caused by the following gramnegative microorganisms. Zerbaxa for injection is indicated for the treatment of patients 18 years or older with the following infections caused by designated susceptible microorganisms. Ceftolozanetazobactam zerbaxa is the combination of cephalosporin ceftolozane plus betalactamase inhibitor tazobactam has activity versus pseudomonas aeruginosa is thought to be better than ceftazidimeavibactam for multidrugresistant pseudomonas aeruginiosa, because ceftolozanetaezobactams structure allows for greater bacterial membrane permeability and more. Positive results for zerbaxa in phase 3 study of ventilated. Urosepsis is associated with mortality of up to 40% among critically ill patients. Ceftolozanetazobactam was approved by the food and drug administration fda on. Jun 03, 2019 zerbaxa ceftolozane and tazobactam is a combination of ceftolozane, a cephalosporin antibacterial, and tazobactam, a betalactamase inhibitor, indicated in patients 18 years or older for the treatment of the following infections caused by designated susceptible microorganisms. It is active against methicillinresistant staphylococcus aureus mrsa and grampositive bacteria. Supplementary inserts specific to each antimicrobial are also available. The package insert states decreased efficacy seen in patients with a baseline creatinine clearance zerbaxa is indicated for the treatment of patients 18 years and older with hospitalacquired bacterial pneumonia and ventilatorassociated bacterial pneumonia habpvabp, caused by the following susceptible gramnegative microorganisms. Aseptic technique must be followed in preparing the infusion solution. Complicated urinarytract infections may affect the lower urinary tract or upper urinary tract pyelonephritis. Each vial contains 50 mg of amphotericin b, usp, intercalated into a liposomal membrane consisting of approximately 0.
Dosing for zerbaxa ceftolozane and tazobactam official site. Bumetanide is a loop diuretic, available in 4 ml and 10 ml vials for intravenous or intramuscular injection as a sterile solution. Zerbaxa, innceftolozanetazobactam european medicines agency. Aseptically transfer the required dose of reconstituted dalbavancin solution from the vials to an intravenous bag or bottle containing 5% dextrose injection, usp. For the etest application guide, select guided search by reagents. Is thought to be better than ceftazidimeavibactam for multidrugresistant pseudomonas aeruginiosa, because ceftolozanetaezobactams structure allows for greater bacterial. Ceftolozanetazobactam therapy of respiratory infections due. Dec 26, 2019 bumetanide is a loop diuretic, available in 4 ml and 10 ml vials for intravenous or intramuscular injection as a sterile solution. Description azactam aztreonam injection contains the active ingredient aztreonam, a monobactam. The reconstituted vial contains 20 mgml dalbavancin as a clear, colorless to yellow solution. Prevent moisture from penetrating into or forming within the package or storage container.